Merck Q1 Preview: Analysts pin hopes on Keytruda, Winrevair for strong Q1 print

Merck is scheduled to report first-quarter earnings on April 30, during market hours, with analysts expecting a strong performance from Keytruda and Winrevair.

FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) granted priority review for two supplemental Biologics License Applications (sBLA) for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph),

Exclusive - Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say

By Sabrina Valle NEW YORK, April 22 (Reuters) - Inhibrx Biosciences has drawn interest from drugmakers including Merck & Co, Germany’s Merck KGaA and Japan's Ono Pharmaceutical for an experimental cancer treatment that could be valued at more than $8 billion,
The Week

Why cancer drug Keytruda costs so much—and who really pays the price?

A game changer in cancer treatment, Keytruda, works by harnessing the body’s immune system to attack cancer cells. While its clinical impact is widely acknowledged, its accessibility remains sharply c
Yahoo

The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt

Add Yahoo as a preferred source to see more of our stories on Google. On the Wednesday, April 15, 2026, episode of The Excerpt podcast: Prices for cutting-edge medical treatments can balloon in the U.S. health care system, leading to higher costs for the ...
RAPS

FDA Alerts on Risks From Merck’s Keytruda in Multiple Myeloma Following Halted Trials

FDA Alerts on Risks From Merck’s Keytruda in Multiple Myeloma Following Halted Trials The US Food and Drug Administration (FDA) on Thursday released an alert and summary of findings from two halted Merck clinical trials evaluating the use of Keytruda (pembrolizumab) combined with other treatments in patients with multiple myeloma.

What is Keytruda? How the cancer drug works and why it's in focus

What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns over pricing, patents, and access in India.
Yahoo

Moderna and MSD’s cancer vaccine plus Keytruda boosts RFS in melanoma study

Add Yahoo as a preferred source to see more of our stories on Google. Moderna and MSD's mRNA cancer vaccine A combination of Moderna and MSD's personalised cancer vaccine, intismeran autogene, and MSD’s stalwart oncology drug, Keytruda (pembrolizumab ...
RAPS

FDA Limits the Use of Tecentriq and Keytruda

The US Food and Drug Administration (FDA) announced Tuesday that it has limited the use of Roche’s Tecentriq (atezolizumab) and Merck’s Keytruda (pembrolizumab) for patients with locally advanced or metastatic urothelial cancer who are not eligible for ...